How fear transforms into anxiety

  • Study sheds new insight into the brain mechanisms at work

Albuquerque, NM, USA (July 9, 2020) — A deadly coronavirus pandemic, economic instability and civil unrest menace the mental well-being of millions. Understanding how, in vulnerable people, fear from such frightening events evolves into lifelong anxiety, is critical for healing.

A University of New Mexico research team led by Elaine L. Bearer, MD, PhD, the Harvey Family Professor in Pathology, and graduate student Taylor W. Uselman has identified for the first time brain-wide neural correlates of the transition from fear to anxiety.

“Until now, psychiatrists had little information about what goes on in the brain after a fearful experience, and why some people don’t easily recover and remain anxious, for even as long as the rest of their lives,” Bearer says.

Werbung

Life-threatening fear frequently leads to post-traumatic stress syndrome (PTSD). The goal is to shed light on the brain’s response to fear and why, in some cases, it can lead to prolonged anxiety states like PTSD.

While not feasible in human subjects, fear can be provoked in rodents by exposure to a scary smell, such as a product commonly used to protect our barbecues from mouse nesting. This smell simulates a predator odor and scares mice away.

The UNM team used this trick to witness how the brain responds to scary events and discover how brain activity evolves from a scary feeling to anxiety.

In a paper published this week in the journal NeuroImage, they report a correlation of behavior with brain activity by watching behavior and capturing magnetic resonance images before, during and after exposure to non-scary and scary smells.

They created vulnerability to anxiety by manipulating the serotonin transporter (SERT), which is the major target of psychoactive drugs, like cocaine, and antidepressants, like Prozac. Deletion of the SERT gene (SERT-KO) produces vulnerability to anxiety, and thus provides a unique model to learn how frightening experiences morph into anxiety.

The UNM researchers compared behavior and brain activity in normal versus SERT-KO to identify the neural correlates of anxiety – those regions active in anxious SERT-KOs and not in normal subjects.

To highlight active neurons, they used manganese, a non-toxic ion that lights up active neurons in magnetic resonance images. Computational analyses of these brain-wide images yielded maps of activity throughout the brain before, immediately and long after brief exposure to the scary smell.

They identified differences in neural activity in 45 sub-regions throughout the brain. Some regions were activated by the scary smell, and some only came on later. Vulnerability to anxiety correlated with much more activity in many more regions.

The function of some of these regions, including the amygdala and hypothalamus, is at least partly understood, but others, such as the reward circuitry, were not previously known to be involved in anxiety.

In anxiety, the coordination between regions was altered, which may represent a brain-wide signature of anxiety, or signify a dis-coordination between brain regions, which is often experienced when we are frightened or anxious.

“We now know that brain activity in anxiety is not the same as in an acute fear response,” Bearer says. “With anxiety, neural activity is elevated across many specific regions of the brain, and normal coordination between regions is lost.”

What does this mean in the time of COVID? The time lag for resilient or anxious outcomes suggests that early containment of fearful responses to surges in cases, protests and economic recession may reduce the likelihood of progression to anxiety.

The involvement of serotonin also suggests pharmacologic targets that could help in reducing the likelihood of anxiety. Meditation, music, poetry, exercise and other stress-reducing activities that engage the reward circuitry will also likely help. Early interventions will have lasting benefits.


University of New Mexico Health Sciences Center, 09.07.2020 (tB).

Schlagwörter:

MEDICAL NEWS

Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Having trouble falling asleep predicts cognitive impairment in later life
SARS-CoV-2 detectable — though likely not transmissible — on hospital…
Waking just one hour earlier cuts depression risk by double…
Moving one step closer to personalized anesthesia

SCHMERZ PAINCARE

Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern
Wenn Schmerzen nach einer OP chronisch werden

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…

ONKOLOGIE

Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung
Risikobasiertes Brustkrebs-Screening kosteneffektiv
Krebs – eine unterschätzte finanzielle Herausforderung

MULTIPLE SKLEROSE

Goldstandard für Versorgung bei Multipler Sklerose
Patienteninformationen zu Interferon-beta-Präparaten
Zulassung des S1P Modulators Ponesimod zur Behandlung von erwachsenen Patienten…
Neue S2k-Leitlinie für Diagnostik und Therapie der Multiplen Sklerose
Krankheitsbezogenes Kompetenznetz Multiple Sklerose: Stellungnahme zu SARS CoV 2 Impfdaten…

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung